Is a complete TPEX/6785 research report available?

No complete published report is available for tpex/6785 (TPEX/6785) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tpex/6785 stock profile: metrics, valuation and analysis

Market cap	6.3B
Revenue (ttm)	3M
Net income (ttm)	-72.1M
EPS (ttm)	-NT$1.08
Shares out	66.8M
Dividend	NT$0.10 (0.11%)
Volume	32,760
Beta	0.12

All TPEX/6785 indicators

Market & fundamental data

Available fields

186

Groups with data

Currency

TWD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	32
Employees Change	5%
Employees Change Percent	18.52
Enterprise value	TWD 4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	40.51
Isin	TW0006785009
Last refreshed	2026-09-12
Market cap	TWD 6.3B
Price	TWD 94
Price currency	TWD
Sector	Healthcare
Sector PE	87.76
Sector PE Fwd	27.81
Sic	2834
Symbol	tpex/6785
Website	https://alarpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.15%
FCF yield	-3.02%
P/B ratio	2.64x
P/S ratio	2,093.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	86.4%
Gross Profit	TWD 2.6M
Gross Profit Growth	-44.77%
Gross Profit Growth Q	22.37%
Gross Profit Growth3 Y	47.97%
Gross Profit Growth5 Y	34%
Net Income	TWD -72.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-1,750.33%
Profitable Quarters	TWD 1
ROA	-4.3
Roa5y	2
ROCE	-7.17
ROE	-2.99
Roe5y	7.38
ROIC	-212.5
Roic5y	283.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-59.38%
Cagr3y	-12.71%
Cagr5y	13.46%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-57.57x
Revenue Growth Q	-0.24x
Revenue Growth Qo Q	400x
Revenue Growth Years	0x
Revenue Growth3 Y	55.36x
Revenue Growth5 Y	37.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0
Assets	TWD 2.4B
Cash	TWD 2.3B
Current Assets	TWD 2.3B
Current Liabilities	TWD 59.8M
Debt	TWD 1.9M
Debt Equity	TWD 0
Debt FCF	TWD -0.01
Equity	TWD 2.4B
Interest Coverage	-2,140.7
Liabilities	TWD 72.3M
Long Term Assets	TWD 131.1M
Long Term Liabilities	TWD 12.6M
Net Cash	TWD 2.3B
Net Cash By Market Cap	TWD 36.36
Net Cash Growth	-2.49%
Net Debt Equity	TWD -0.96
Tangible Book Value	TWD 2.4B
Tangible Book Value Per Share	TWD 35.58
WACC	4.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	38.77
Net Working Capital	TWD -24.6M
Quick ratio	38.22
Working Capital	TWD 2.3B
Working Capital Turnover	TWD 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.89%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	TWD 0.1
Dividend Years	3
Dividend Yield	0.11%
Ex Div Date	2026-08-25
Last Dividend	TWD 0.1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-59.35%
200-day SMA	176.2
3Y total return	-33.49%
50-day SMA	102.8
50-day SMA vs 200-day SMA	50under200
5Y total return	88.04%
All Time High	465
All Time High Change	-79.78%
All Time High Date	2024-02-21
All Time Low	42.8
All Time Low Change	119.63%
All Time Low Date	2022-01-21
ATR	3.17
Beta	0.12
Beta1y	0.83
Beta2y	0.85
Ch YTD	-69.08
High	96.7
High52	317
High52 Date	2025-12-26
High52ch	-70.35%
Low	93.1
Low52	90.6
Low52 Date	2026-09-03
Low52ch	3.75%
Ma50ch	-8.53%
Price vs 200-day SMA	-46.64%
RSI	42.38
RSI Monthly	38.04
RSI Weekly	27.78
Sharpe ratio	-1.38x
Sharpe Ratio3y	-0.03x
Sharpe Ratio5y	0.42x
Sortino ratio	-1.7
Sortino Ratio3y	0.06
Sortino Ratio5y	0.8
Total Return	-0.78%
Tr YTD	-69.05
Tr1m	-6.84%
Tr1w	3.64%
Tr3m	-18.18%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40,288,203%
Net Borrowing	-3,412,000
Shares Insiders	24.57%
Shares Institutions	7.63%
Shares Out	66,800,000
Shares Qo Q	0%
Shares Yo Y	0.89%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	57,464.85x
Bv Per Share	35.58
CAPEX	TWD -3M
Ch1m	-6.93
Ch1w	3.64
Ch1y	-59.4
Ch3m	-18.26
Ch3y	-34.04
Ch5y	86.51
Ch6m	-51.42
Change	-1.67%
Change From Open	-2.79
Close	95.6
Days Gap	1.15
Depreciation Amortization	2,805,000
Dollar Volume	3,079,440
Earnings Date	2026-11-06
EBIT	TWD -171.3M
EBITDA	TWD -168.4M
EPS	TWD -1.08
F Score	2
FCF	TWD -189.6M
FCF EV Yield	-4.75x
FCF Per Share	TWD -2.84
Financing CF	-20,112,000
Fiscal Year End	December
Founded	2,016
Income Tax	TWD 19.6M
Investing CF	500,693,000
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2026-06-30
Ma150	143.9
Ma150ch	-34.66%
Ma20	95.81
Ma20ch	-1.88%
Net CF	311,174,000
Next Earnings Date	2026-11-06
Open	96.7
Payment Date	2026-09-14
Position In Range	25
Ppne	13,932,000
Price Date	2026-09-11
Ptbv Ratio	2.64
Relative Volume	0.57x
Revenue	3,000,000x
Tax By Revenue	653.93x
Tr6m	-51.37%
Volume	32,760
Z Score	114.8

TPEX/6785 (TPEX/6785)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6785

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6785 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6785

Frequently asked questions